These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10198068)

  • 1. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
    Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
    Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
    Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.
    Serra R; Johnson M; Filvaroff EH; LaBorde J; Sheehan DM; Derynck R; Moses HL
    J Cell Biol; 1997 Oct; 139(2):541-52. PubMed ID: 9334355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta, c-Cbl, and PDGFR-alpha the in mammary stroma.
    Crowley MR; Bowtell D; Serra R
    Dev Biol; 2005 Mar; 279(1):58-72. PubMed ID: 15708558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
    Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
    Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
    Crowley MR; Frost A; Chen DT; Baffi MO; Nicola T; Serra R
    Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
    Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
    Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
    Miettinen PJ; Ebner R; Lopez AR; Derynck R
    J Cell Biol; 1994 Dec; 127(6 Pt 2):2021-36. PubMed ID: 7806579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
    Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
    Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
    Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
    Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelium-specific adenoviral transfer of a dominant-negative mutant TGF-beta type II receptor stimulates embryonic lung branching morphogenesis in culture and potentiates EGF and PDGF-AA.
    Zhao J; Sime PJ; Bringas P; Gauldie J; Warburton D
    Mech Dev; 1998 Mar; 72(1-2):89-100. PubMed ID: 9533955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.
    Siegel PM; Shu W; Cardiff RD; Muller WJ; Massagué J
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8430-5. PubMed ID: 12808151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.
    Bierie B; Gorska AE; Stover DG; Moses HL
    J Cell Physiol; 2009 Apr; 219(1):57-68. PubMed ID: 19086032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
    Maeda M; Shintani Y; Wheelock MJ; Johnson KR
    J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
    Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D
    Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
    Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
    J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
    Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
    EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.
    Jhappan C; Geiser AG; Kordon EC; Bagheri D; Hennighausen L; Roberts AB; Smith GH; Merlino G
    EMBO J; 1993 May; 12(5):1835-45. PubMed ID: 8491177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
    Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
    J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.